Human glioblastoma cells display mesenchymal stem cell features and form intracranial tumors in immunocompetent rats

Journal of Stem Cells

Volumn 5, Issue 3, 2011, Pages 103-111

  Nakahata, Adriana M ^a,b   Suzuki, Daniela E ^a,b   Rodini, Carolina O ^b   Pereira, Márcia C L ^a,b   Janjoppi, Luciana ^a,b   Okamoto, Oswaldo Keith ^b  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Glioblastomas; Immunocompetent rats; Mesenchymal stem cells; Xenograft orthotopic model

Indexed keywords

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN HEMORRHAGE; BRAIN NECROSIS; CANCER CELL; CONTROLLED STUDY; FLOW CYTOMETRY; GLIOBLASTOMA; HUMAN; HUMAN CELL; IMMUNOCOMPETENCE; IN VITRO STUDY; IN VIVO STUDY; INTRACRANIAL TUMOR; MALE; MESENCHYMAL STEM CELL; MOTOR CORTEX; NONHUMAN; PHENOTYPE; RAT;

ANIMALS; BRAIN NEOPLASMS; CELL DIFFERENTIATION; CELL SHAPE; CHONDROGENESIS; GLIOBLASTOMA; HUMANS; IMMUNOCOMPETENCE; MALE; MESENCHYMAL STEM CELLS; NEOPLASM TRANSPLANTATION; OSTEOGENESIS; RATS; RATS, WISTAR; TRANSPLANTATION, HETEROLOGOUS; TUMOR CELLS, CULTURED;

RATTUS;

EID: 84858806438     PISSN: 15568539     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Al-Hajj, M., Wicha, M.S., Benito-Hernandez, A., Morrison, S.J., Clarke, M.F. Prospective identification of tumorigenic breast cancer cells. Proceedings of the National Academy of Sciences of the United States of America., 2003;100, 3983-3988.
2. Singh, S.K., Hawkins, C., Clarke, I.D., Squire, J.A., Bayani, J., Hide, T., Henkelman, R.M., Cusimano, M.D., Dirks, P.B. Identification of human brain tumour initiating cells. Nature., 2004;432, 396-401.
3. Collins, A.T., Berry, P.A., Hyde, C., Stower, M.J., Maitland, N.J. Prospective identification of tumorigenic prostate cancer stem cells. Cancer Research., 2005; 65,10946-10951.
4. Patrawala, L., Calhoun, T., Schneider-Broussard, R., Li, H., Bhatia, B., Tang, S., Reilly, J.G., Chandra, D., Zhou, J., Claypool, K., Coghlan, L., Tang, D.G. Highly purified CD44+ prostate cancer cells from xenograft human tumors are enriched in tumorigenic and metastatic progenitor cells. Oncogene., 2006;25, 1696-1708.
5. Li, C., Heidt, D. G, Dalerba, P., Burant, C.F., Zhang, L., Adsay, V., Wicha, M., Clarke, M.F., Simeone, D.M. Identification of pancreatic cancer stem cells. Cancer Resarch., 2007;67,1030-1037.
6. O'Brien, C.A., Pollett, A., Gallinger, S., Dick, J.E. A human colon cancer cell capable of initiating tumour growth in immunodeficient mice. Nature., 2007;445, 106-110.
7. Prince, M.E., Sivanandan, R., Kaczorowski, A., Wolf, G.T., Kaplan, M.J., Dalerba, P., Weissman, I.L., Clarke, M.F., Ailles, L.E. Identification of a subpopulation of cells with cancer stem cell properties in head and neck squamous cell carcinoma. Proceedings of the National Academy of Sciences of the United States of America., 2007;104, 973-978.
8. Ricci-Vitiani, L., Lombardi, D.G., Pilozzi, E., Biffoni, M., Todaro, M., Peschle, C, De Maria, R. Identification and expansion of human colon-cancer-initiating cells. Nature., 2007;445, 111-115.
9. Okamoto, O.K., Perez, J.F. Targeting cancer stem cells with monoclonal antibodies: a new perspective in cancer therapy and diagnosis. Expert Review Molecular Diagnostics., 2008;8(4):387-93.
10. Hirschmann-Jax, C., Foster, A.E., Wulf, G.G., Nuchtern, J.G., Jax, T.W., Gobel, U., Goodell, M.A., Brenner, M.K. A distinct "side population" of cells with high drug efflux capacity in human tumor cells. Proceedings of the National Academy of Sciences of the United States of America., 2004;101, 14228-14233.
11. Hadnagy, A., Gaboury, L., Beaulieu, R., Balicki, D. SP analysis may be used to identify cancer stem cell populations. Experimental Cell Research., 2006;312, 3701-3710.
12. Jørgensen, H.G., Holyoake, T.L. Characterization of cancer stem cells in chronic myeloid leukaemia. Biochemical Society Transactions., 2007;35(Pt 5), 1347-1351.
13. Nakai, E., Park, K., Yawata, T., Chihara, T., Kumazawa, A., Nakabayashi, H., Shimizu, K. Enhanced MDR1 expression and chemoresistance of cancer stem cells derived from glioblastoma. Cancer Investigation., 2009;27(9):901-8.
14. Liu, G., Black, K. L, Yu, JS. Sensitization of malignant glioma to chemotherapy through dendritic cell vaccination. Expert Review of Vaccines., 2006;5, 233-247.
15. Phillips, T.M., McBride, W.H., Pajonk, F. The response of CD24(_/low)/CD44+ breast cancer-initiating cells to radiation. Journal of the National Cancer Institute., 2006;98, 1777-1785.
16. Yu, S.C., Ping, Y.F., Yi, L., Zhou, Z.H., Chen, J.H., Yao, X.H., Gao, L., Wang, J.M., Bian, X.W. Isolation and characterization of cancer stem cells from a human glioblastoma cell line U87. Cancer Letters, 2008;28;265(1):124-34.
17. Wu, A., Oh, S., Wiesner, S.M., Ericson, K., Chen, L., Hall, W.A., Champoux, P.E., Low, W.C., Ohlfest, J.R. Persistence of CD133+ cells in human and mouse glioma cell lines: detailed characterization of GL261 glioma cells with cancer stem cell-like properties. Stem Cells and Development., 2008;17(1):173-84.
18. Qiang, L., Yang, Y., Ma, Y.J., Chen, F.H., Zhang, L.B., Liu, W., Qi, Q., Lu, N., Tao, L., Wang, X. T, You, Q.D., Guo, Q.L. Isolation and characterization of cancer stem like cells in human glioblastoma cell lines. Cancer Letters., 2009;279(1):13-21.
19. Fukaya, R., Ohta, S., Yamaguchi, M., Fujii, H., Kawakami, Y., Kawase, T., Toda, M. Isolation of cancer stem-like cells from a side population of a human glioblastoma cell line, SK-MG-1. Cancer Letters., 2010;291(2):150-7.
20. Beier, D., Hau, P., Proescholdt, M., Lohmeier, A., Wischhusen, J., Oefner, P.J., Aigner, L., Brawanski, A., Bogdahn, U., Beier, C.P. CD133(+) and CD133(-) glioblastoma-derived cancer stem cells show differential growth characteristics and molecular profiles. Cancer Research., 2007;67(9):4010-5.
21. Nishide, K., Nakatani, Y., Kiyonari, H., Kondo, T. Glioblastoma formation from cell population depleted of Prominin1-expressing cells. PLoS One., 2009;4(8):e6869.
22. Sun, Y., Kong, W., Falk, A., Hu, J., Zhou, L., Pollard, S., and Smith, A. CD133 (Prominin) negative human neural stem cells are clonogenic and tripotent. PLoS One., 2009;4(5):e5498.
23. Secco, M., Zucconi, E., Vieira, N.M., Fogaça, L.L., Cerqueira, A., Carvalho, M.D., Jazedje, T., Okamoto, O.K., Muotri, A.R., Zatz, M. Multipotent stem cells from umbilical cord: cord is richer than blood! Stem Cells., 2008;26(1):146-50.
24. Paxinos, G., Watson, C. The rat brain: in stereotaxic coordinates. Academic Press. San Diego, 1995 second edition.
25. Galli, R., Binda, E., Orfanelli, U., Cipelletti, B., Gritti, A., De Vitis, S., Fiocco, R., Foroni, C., Dimeco, F., Vescovi, A. Isolation and characterization of tumorigenic, stem-like neural precursors from human glioblastoma. Cancer Research., 2004;64(19):7011-21.
26. Bao, S., Wu, Q., McLendon, R.E., Hao, Y., Shi, Q., Hjelmeland, A.B., Dewhirst, M.W., Bigner, D.D., Rich, J.N. Glioma stem cells promote radioresistance by preferential activation of the DNA damage response. Nature., 2006;444(7120):756-60.
27. Rieske, P., Golanska, E., Zakrzewska, M., Piaskowski, S., Hulas-Bigoszewska, K., Wolańczyk, M., Szybka, M., Witusik-Perkowska, M., Jaskolski, D.J., Zakrzewski, K., Biernat, W., Krynska, B., Liberski, P.P. Arrested neural and advanced mesenchymal differentiation of glioblastoma cells-comparative study with neural progenitors. BMC Cancer., 2009;9:54.
28. Ricci-Vitiani, L., Pallini, R., Larocca, L.M., Lombardi, D.G., Signore, M., Pierconti, F., Petrucci, G., Montano, N., Maira, G., De Maria, R. Mesenchymal differentiation of glioblastoma stem cells. Cell Death Differentiation., 2008;9:1491-8.
29. Battula, V.L., Evans, K.W., Hollier, B.G., Shi, Y., Marini, F.C., Ayyanan, A., Wang, R.Y., Brisken, C., Guerra, R., Andreeff, M., Mani, S.A. Epithelial-Mesenchymal Transition-Derived Cells Exhibit Multi-Lineage Differentiation Potential Similar to Mesenchymal Stem Cells. Stem Cells., 2010;8:1435-45.
30. Okada, H., Kohanbash, G., Zhu, X., Kastenhuber, E.R., Hoji, A., Ueda, R., Fujita, M. Immunotherapeutic approaches for glioma. Critical Reviews Immunology., 2009;29(1):1-42.
31. Albesiano, E., Han, J.E., Lim, M. Mechanisms of local immunoresistance in glioma. Neurosurgery., Clinics of North America., 2010;21(1):17-29.
32. Kaye, A.H., Morstyn, G., Gardner, I., Pyke, K. Development of a xenograft glioma model in mouse brain. Cancer Research., 1986;46(3):1367-73.
33. Morandi, F., Raffaghello, L., Bianchi, G., Meloni, F., Salis, A., Millo, E., Ferrone, S., Barnaba, V., Pistoia, V. Immunogenicity of human mesenchymal stem cells in HLA-class I-restricted T-cell responses against viral or tumor-associated antigens. Stem Cells., 2008;5:1275-1287.